Production (Stage)
eXoZymes, Inc.
EXOZ
$12.81
-$0.34-2.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -700.00 | -700.00 | 10.90K |
| Total Other Revenue | -- | -- | 70.10K | 70.10K | 70.10K |
| Total Revenue | -- | -- | -700.00 | -700.00 | 10.90K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -700.00 | -700.00 | 10.90K |
| SG&A Expenses | 4.71M | 4.06M | 3.23M | 2.71M | 1.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.87M | 5.93M | 4.93M | 3.71M | 2.57M |
| Operating Income | -6.87M | -5.93M | -4.93M | -3.71M | -2.56M |
| Income Before Tax | -6.71M | -5.86M | -5.08M | -3.94M | -2.76M |
| Income Tax Expenses | 0.00 | 0.00 | 44.40K | 44.40K | 42.30K |
| Earnings from Continuing Operations | -6.71 | -5.86 | -5.12 | -3.99 | -2.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.71M | -5.86M | -5.12M | -3.99M | -2.81M |
| EBIT | -6.87M | -5.93M | -4.93M | -3.71M | -2.56M |
| EBITDA | -6.60M | -5.66M | -4.68M | -3.47M | -2.35M |
| EPS Basic | -0.95 | -0.89 | -0.82 | -0.64 | -0.45 |
| Normalized Basic EPS | -0.59 | -0.56 | -0.51 | -0.39 | -0.28 |
| EPS Diluted | -0.95 | -0.89 | -0.82 | -0.64 | -0.45 |
| Normalized Diluted EPS | -0.59 | -0.56 | -0.51 | -0.39 | -0.28 |
| Average Basic Shares Outstanding | 28.37M | 26.25M | 25.00M | 25.00M | 25.00M |
| Average Diluted Shares Outstanding | 28.37M | 26.25M | 25.00M | 25.00M | 25.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |